United Therapeutics (UTHR) Misses Q4 EPS by 49c
Tweet
Share
E-mail
Get Alerts UTHR Hot Sheet
Price: $513.85 +0.68%
EPS Growth %: -10.1%
Financial Fact:
Net income per basic common share (in dollars per share): 3.75
Today's EPS Names:
PMCB, PLCE, DOMO, More
EPS Growth %: -10.1%
Financial Fact:
Net income per basic common share (in dollars per share): 3.75
Today's EPS Names:
PMCB, PLCE, DOMO, More
Join SI Premium – FREE
United Therapeutics (NASDAQ: UTHR) reported Q4 EPS of $6.19, $0.49 worse than the analyst estimate of $6.68. Revenue for the quarter came in at $735.9 million versus the consensus estimate of $739.92 million.
For earnings history and earnings-related data on United Therapeutics (UTHR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Dell Technologies (DELL) Tops Q2 EPS by $2.17, Offers Guidance
- PG&E Corp. (PCG) 30K contracts of September 17 calls, 29K contracts of December 18 calls trade
- Los Andes Copper Announces Election to Issue Common Shares in Satisfaction of US$9 Million Convertible Debenture Interest Payment Obligations
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
